docetaxel anhydrous has been researched along with Remission, Spontaneous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gregoriou, S; Platsidaki, E; Rigopoulos, D; Sidiropoulou, P | 1 |
| Endo, Y; Fujisawa, A; Miyachi, Y; Nomura, T; Tanioka, M; Tokunaga, M | 1 |
2 other study(ies) available for docetaxel anhydrous and Remission, Spontaneous
| Article | Year |
|---|---|
Nails with bloodstained discoloration.
Topics: Antineoplastic Agents; Diagnosis, Differential; Docetaxel; Female; Hemorrhage; Humans; Middle Aged; Nail Diseases; Onycholysis; Patient Care Management; Pigmentation Disorders; Quality of Life; Remission, Spontaneous; Withholding Treatment | 2021 |
Improvement in telangiectatic rosacea as a side-effect of monthly docetaxel therapy.
Topics: Aged; Antineoplastic Agents; Docetaxel; Facial Dermatoses; Humans; Incidental Findings; Male; Middle Aged; Nose; Nose Diseases; Recurrence; Remission, Spontaneous; Rosacea; Taxoids; Telangiectasis | 2014 |